Rivaroxaban for treating chronic heart failure [ID1462]
Awaiting development
Reference number: GID-TA10393
Expected publication date: TBC
The company that manufacture rivaroxaban has advised NICE that they are no longer pursuing a licence in the UK for this product for this indication at this time. In light of this information the Institute will not be progressing with the scoping exercise. Consequently, the consultation on the draft scope has now been closed early. Thank you for any comments that have already been received.
If you have any comments or concerns please contact the project manager for this proposed appraisal Emily Richards on (44 (0)161 413 4070 or via email on emily.richards@nice.org.uk)